Spero Therapeutics (SPRO) Net Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -236,257.00 |
| Dec 31, 2025 | -29,322.00 |
| Sep 30, 2025 | -12,368.00 |
| Jun 30, 2025 | 22,406.00 |
| Mar 31, 2025 | -15,650.00 |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | -2.69 Mn |
| Jun 30, 2024 | -16,605.00 |
| Mar 31, 2024 | -22,064.00 |
| Dec 31, 2023 | 154,968.00 |
| Sep 30, 2023 | -102,716.00 |
| Jun 30, 2023 | 550,954.00 |
| Mar 31, 2023 | -611,183.00 |
| Dec 31, 2022 | 73,549.00 |
| Sep 30, 2022 | 73,138.00 |
| Jun 30, 2022 | 15,349.00 |
| Mar 31, 2022 | -127,889.00 |
| Dec 31, 2021 | 299,104.00 |
| Sep 30, 2021 | -229,210.00 |
| Jun 30, 2021 | -61,209.00 |
| Sep 30, 2020 | -4.89 Mn |
| Jun 30, 2020 | 26,284.00 |
| Mar 31, 2020 | 234,516.00 |
| Dec 31, 2019 | -329,417.00 |
| Sep 30, 2019 | 1.94 Mn |
| Jun 30, 2019 | -1.98 Mn |
| Mar 31, 2019 | 55,571.00 |
| Dec 31, 2018 | 96,370.00 |
| Sep 30, 2018 | 56,020.00 |
| Dec 31, 2017 | 53,537.00 |
| Sep 30, 2017 | 284,509.00 |
| Jun 30, 2017 | 22,499.00 |
| Mar 31, 2017 | -1.79 Mn |
| Dec 31, 2016 | 2.02 Mn |